Ursodil

Quick links to important sections

Ursodil

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ursodil

What is Ursodil?

Ursodil is a pharmaceutical formulation containing ursodeoxycholic acid, which is a naturally occurring bile acid found in small quantities in human bile. It belongs to the class of medications known as bile acid analogs or hepatotropic agents.

Mechanism of Action

Ursodil works by modifying the composition of bile in the gallbladder and liver. It performs several primary functions within the biliary system:

  • Reduction of Cholesterol Secretion: It decreases the amount of cholesterol produced by the liver and absorbed by the intestines.
  • Bile Acid Replacement: By increasing the proportion of ursodeoxycholic acid, it displaces more toxic, hydrophobic bile acids that can damage liver cell membranes.
  • Cholesterol Dissolution: It helps disperse cholesterol that has precipitated out of bile, which assists in the gradual breakdown of certain types of gallstones.
  • Cytoprotection: It helps protect liver cells from the inflammatory effects of bile buildup.

Primary Uses

Ursodil is utilized in the management of chronic cholestatic liver diseases and gallbladder conditions. Its use is generally focused on:

  1. Dissolution of Gallstones: It is used for patients with small, radiolucent (non-calcified) gallstones who are not candidates for surgical intervention.
  2. Primary Biliary Cholangitis (PBC): It is a standard treatment to help slow the progression of this chronic disease, which involves the gradual destruction of the bile ducts in the liver.
  3. Biliary Sludge Prevention: It may be used in specific clinical scenarios where rapid weight loss increases the risk of stone formation.

What side effects are possible with Ursodil?

Possible side effects and safety information

The safety profile of Ursodil (ursodeoxycholic acid) is formally documented by regulatory authorities, classifying possible adverse reactions by frequency and the physiological system affected. The information is consistent across official labels and is presented in a high-level, descriptive manner.

Frequency-Classified Adverse Reactions

The most frequently reported effects are generally categorized as Common (ge 1/100 to < 1/10) and affect the gastrointestinal system. These typically include Diarrhoea (or loose stools) and Pasty stools.

Reactions classified as Very Rare (< 1/10,000) include Severe right upper abdominal pain, the potential for Decompensation of hepatic cirrhosis (observed in advanced disease stages), the Calcification of gallstones, and Urticaria (hives).

Other reactions such as Nausea and Pruritus (itching) have been documented in postmarketing experience, but their frequency is categorized as Not Known across regulatory documents.

System-Organ Class Examples of Documented Effects
Gastrointestinal disorders Diarrhoea, Pasty stools, Abdominal discomfort, Vomiting
Hepatobiliary disorders Calcification of gallstones, Hepatic cirrhosis decompensation
Skin disorders Urticaria, Pruritus, Rash

Safety Considerations and Restrictions

Official labeling mandates monitoring requirements during therapy, specifically requiring Liver function tests to be conducted monthly for the first three months, and every six months thereafter. Treatment discontinuation is advised if parameters rise to a clinically significant level.

Use of Ursodil is restricted under certain conditions. It must not be used in patients with acute inflammation of the gallbladder or biliary tract, complete biliary tract occlusion, radio-opaque calcified gallstones, or impaired contractility of the gallbladder. Furthermore, use during Pregnancy is generally contraindicated due to a lack of adequate data and evidence of potential risk in animal studies.

Overdose and Emergency Response

Ursodil Overdose and When to Seek Help

The official regulatory documentation for Ursodil addresses overdose scenarios by detailing the expected clinical signs and required emergency actions. This information is derived exclusively from government health authority documents.

Documented Manifestations and Toxicity Profile

The most likely clinical sign of a severe overdose with ursodeoxycholic acid is explicitly documented as diarrhea. Regulatory findings indicate that severe systemic effects are considered unlikely because the absorption of the drug decreases at increasing doses, a factor that limits potential systemic toxicity and promotes increased excretion via the feces. Symptoms such as pasty stools may also be associated with high exposures, but the primary clinical manifestation noted is persistent or severe diarrhea.

Regulatory Mandates for Emergency Care

Immediate medical attention is officially required upon the recognition of any adverse drug reaction, including a potential overdose scenario. The official management guidance is primarily symptomatic and procedural. Symptomatic treatment is mandated for the manifestation of diarrhea. If deemed necessary by healthcare professionals, interventions such as the use of ion-exchange resins may be employed to bind bile acids within the intestines. Regulatory guidelines also specify that liver function should be formally monitored in the event of a known or suspected overdose. Persistent diarrhea, regardless of confirmed overdose, requires the mandated discontinuation of Ursodil therapy.

Therapeutic Uses of Ursodil

What Ursodil Treats: Main Uses and Benefits

Ursodil (ursodeoxycholic acid) is primarily applied in managing specific conditions and symptoms affecting the liver and gallbladder. This medication is relevant in clinical scenarios where supportive symptom management is appropriate or specific disease management is needed. It is commonly used to help with conditions presenting with systemic or localized discomfort.

Therapeutic Uses and Patient Support

Ursodil is used in situations involving certain distressing symptoms related to the gallbladder, in conditions characterized by periods of heightened symptoms such as Primary Biliary Cholangitis (PBC), and in clinical settings where supportive management is appropriate. In clinical settings, it is applied in addressing symptom clusters that may interfere with daily comfort. The medicine provides support that helps ease the overall burden of symptoms. It offers symptomatic relief that helps patients cope more steadily during episodes of heightened symptoms.

“The medication is used when supportive symptom management is appropriate.”

Quick Fact

Quick Fact: Support for Physiological Strain

Ursodil assists with managing symptoms related to temporary functional strain or symptoms linked to organ-specific functional stress.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Ursodil (ursodeoxycholic acid) eligibility is strictly defined by regulatory documents, distinguishing approved populations from those for whom use is restricted or contraindicated.

Populations for Whom Use is Contraindicated

Patients must not use Ursodil if they have known hypersensitivity to the active substance or excipients, a complete obstruction of the biliary tract, or acute inflammation of the gallbladder (acute cholecystitis). Additionally, use is forbidden for patients with a non-functioning gallbladder or those with calcified radio-opaque gallstones, which the medicine cannot dissolve.

Eligibility Rules and Restrictions

Category Eligibility Status (Regulatory)
Age (Adults) Use is established for approved adult indications.
Age (Pediatric) Use is generally not established for adult indications; approved for children over 6 years only for specific cystic fibrosis-associated hepatobiliary disorders.
Pregnancy Must not be used unless clearly necessary, based on animal study data and regulatory warnings.
Lactation Not recommended due to unknown excretion into breast milk.
Severe Liver Disease Patients with complications like ascites or hepatic encephalopathy are excluded from standard treatment.

Women of childbearing potential must use a reliable non-hormonal contraceptive method during treatment to avoid pregnancy and counteract potential drug interactions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details official interaction patterns documented in regulatory sources for Ursodeoxycholic acid (Ursodil).

Substances Requiring Separation or Monitoring

Ursodeoxycholic acid has documented pharmacokinetic interactions primarily concerning absorption and enhanced exposure of co-administered medicines.

Interaction Type Interacting Substance/Class Official Outcome/Regulatory Constraint
Reduced Absorption Bile acid sequestrants (e.g., Cholestyramine, Colestipol) and Aluminum-containing antacids (e.g., Aluminum Hydroxide) Administration must be separated by at least 2 hours to prevent reduced Ursodil effectiveness by binding the bile acid in the intestine.
Increased Exposure Cyclosporine, Rosuvastatin Systemic plasma concentrations of these drugs may be increased; monitoring of Cyclosporine levels is required by official documents to manage this effect.
Reduced Exposure Nitrendipine, Dapsone Plasma levels of these drugs are officially documented to be reduced by co-administration.

Interactions Counteracting Efficacy

The effectiveness of Ursodil when used for gallstone dissolution is compromised by substances that increase cholesterol secretion. Co-administration with estrogenic hormones, oral contraceptives, or lipid-lowering drugs (e.g., Clofibrate) is not recommended for this specific treatment purpose as they promote cholesterol gallstone formation. For female patients undergoing gallstone dissolution, regulatory documents specify the use of effective non-hormonal contraception.

No significant adverse interactions with food, alcohol, or herbal products have been documented in the official prescribing information.

Mechanism of Action

Modulation of Bile Chemistry and Cellular Mechanisms

Ursodeoxycholic acid (mathbfUDCA) functions through dual, interconnected pharmacodynamic domains. Its cholelitholytic mechanism is rooted in the liver and intestine, where it exerts an inhibitory effect on cholesterol synthesis and intestinal absorption. This action results in bile with a reduced cholesterol saturation index, which facilitates the dispersion of cholesterol from a crystalline to a soluble liquid-crystalline phase in the bile.

The hepatoprotective mechanism focuses on cellular integrity. UDCA acts as a competitive replacement agent, displacing toxic hydrophobic bile acids from the circulating pool. Intracellularly, it exerts an anti-apoptotic mechanism by stabilizing the mitochondrial membrane of hepatocytes, specifically inhibiting the formation of the mitochondrial permeability transition pore (mathbfMPTP), resulting in preservation of hepatocyte function against toxic bile acid exposure.

mathbfUDCA also stimulates a choleretic mechanism involving the upregulation of transporters like the chloride-bicarbonate anion exchanger (mathbfAE2) to enhance bile flow and volume. Concurrently, it engages an immunomodulatory effect by influencing transcription factors (mathbfNFmathbf-kappamathbfB), a process that results in the suppression of inflammatory signaling pathways within the hepatic tissue.

Dosage and Administration Information

How Ursodil is Used: Official Administration Guidelines

Ursodeoxycholic acid (Ursodil) is an oral medication whose usage is defined by specific protocols. The administration route is exclusively oral, utilizing forms such as capsules, tablets, or oral suspension. The fundamental principle for dosing is weight-dependent, requiring calculation based on the patient’s body weight (milligram per kilogram, mg/kg), rather than a fixed standard dose. For instance, treatment regimens for Primary Biliary Cholangitis (PBC) typically fall within the range of 12-16 mg/kg/day.


Dosing Schedule and Administration Context

Daily administration is standard, often beginning with divided doses taken throughout the day. With progress, the regimen may be consolidated to a single dose taken in the evening or at bedtime, a common practice for treatments like gallstone dissolution. To ensure proper absorption and efficacy, the medication is generally directed to be taken with food or after a meal, a procedural requirement stated in official prescribing information.

Tablets and capsules must be swallowed whole with water. However, some scored tablets are approved to be carefully broken to achieve precise dosing, with the resulting segments also required to be swallowed unchewed. An essential procedural constraint specifies that Ursodil should not be taken within two hours of certain agents, such as aluminum-containing antacids or bile acid sequestrants, to avoid interference with its absorption.


Duration and Specific Populations

Treatment duration varies by condition. For PBC, therapy is frequently long-term and may be continued indefinitely. In contrast, gallstone dissolution requires a defined course, typically 6 to 24 months, followed by a continuation period of three to four months after radiological confirmation of dissolution.

Recent Clinical Evidence

The clinical evaluation of Ursodil (ursodeoxycholic acid) has primarily focused on its evaluation in research studies exploring conditions related to bile composition and liver health. The evidence available comes from various scientific approaches, including large-scale Randomized Controlled Trials (RCTs), systematic reviews, and long-term observational studies, which describe measured patterns across different patient groups.


Evidence for Use in Primary Biliary Cholangitis (PBC)

Research has primarily focused on the use of Ursodil in adult patients with Primary Biliary Cholangitis (PBC), a long-term liver condition. Research examined outcomes related to long-term disease progression and was conducted in patients with varying symptom burdens.

These studies monitored key outcomes such as the timing of a liver transplant or death, which together form a composite outcome that researchers used to measure major disease milestones. They also studied outcomes related to systemic or functional imbalance, specifically tracking changes in liver enzyme levels like Alkaline Phosphatase (ALP) and Bilirubin, which were monitored in studies.

Studies reported measurements related to these biochemical markers, describing patterns observed in the populations studied. Researchers defined and tracked a subgroup referred to as biochemical non-responders, whose long-term outcomes are not fully established by the existing evidence.


Evidence for Gallstone Dissolution and Prevention

Ursodil was also evaluated in research contexts involving studies exploring gallstone management. This research examined studies exploring gallstone dissolution for certain kinds of gallstones. The studies explored the effect on adult patients who had small, non-calcified, and radiolucent cholesterol gallstones within a functioning gallbladder.

Research describes specific rates of gallstone dissolution confirmed by imaging, noting that results apply only to the specific stone compositions studied. Randomized studies also explored the use of Ursodil for the prevention of gallstone formation in certain high-risk groups, such as patients who experience rapid weight loss after bariatric surgery.


Long-Term Research and Study Limitations

Long-term effects are not fully established by shorter RCTs. For PBC, studies monitored responses over defined time intervals, with some follow-up durations extending to ten years or more through observational research. These long-term studies describe patterns related to disease progression and survival. Data for certain groups, particularly non-adult populations, remain insufficient, and long-term data for other indications, like gallstone dissolution, are limited.

Frequently Asked Questions (FAQ)

Common questions about Ursodil (FAQ)

Q: How quickly is it absorbed and when will I start to feel better?

Regulatory documents describe the medicine as being well absorbed in the body. The concentration of the active substance in bile, which is necessary for the full pharmacological effect, takes about three weeks of continuous dosing to reach a stable level. It is important to note that treatment for conditions like gallstone dissolution is a slow process that requires many months.

Q: Is hair loss (alopecia) a known side effect?

Official reports from clinical studies for gallstone dissolution indicate that hair loss (alopecia) is a possible side effect. In one study, this side effect was reported in 5.3% of the patients who received the medicine.

Q: Can I still take it if my gallbladder has been removed?

The medicine has approved indications for chronic liver conditions like primary biliary cholangitis, which are treated regardless of gallbladder status. Use is restricted, however, if the gallbladder is determined to be non-functioning.

Q: Does this medicine have any effect on my immune system?

The active substance is documented to have immunomodulatory effects. Official product information indicates this includes influencing certain immune responses, such as cytokine production, within the liver tissue.

Q: What is the difference between ursodiol, ursodeoxycholic acid, and Ursoforte?

Ursodeoxycholic acid (UDCA) is the active drug substance, which is the official generic name. Ursodil, Ursodiol, and Ursoforte are examples of brand names under which this same active substance is manufactured and marketed.

Q: Is it made from synthetic ingredients or from bear bile?

The active substance is a synthetic version of a naturally occurring bile acid. While it is structurally related to a compound found in human bile, the medicine itself is synthetically manufactured to ensure consistent purity and concentration.

Q: Is it a choleretic (does it increase bile flow)?

Yes, official pharmacological information confirms that the active substance has a choleretic effect. This means that one of its functions is to increase the output and flow of bile acid from the liver.

Q: What is the maximum amount of time I can take it?

For approved chronic conditions like primary biliary cholangitis, official documentation indicates that the therapeutic use of this medicine may be long-term and is not limited by a defined duration. For gallstone dissolution, a defined course of treatment is required.

Q: What should I do if I forget or miss a dose?

Official patient information indicates that if a dose is forgotten, the medicine may be taken as soon as the patient remembers. If it is close to the time for the next dose, the instruction is typically to skip the missed dose and continue with the normal schedule.

Q: Is it safe to take long-term (e.g., for years)?

Long-term therapeutic use is described in regulatory documents for specific chronic liver diseases like primary biliary cholangitis. This long-term use is associated with mandated regulatory requirements for regular monitoring of liver function.

Q: What kind of monitoring or blood tests are needed while on this medicine?

Official labeling requires that liver function parameters (such as AST, ALT, and gamma-GT) be checked by your physician. This monitoring is typically done every four weeks for the first three months of treatment, and then every three months thereafter.

Q: Can it dissolve all types of gallstones?

No, the medicine is indicated for the dissolution of certain types of gallstones, specifically radiolucent (non-calcified) cholesterol gallstones. It is described as ineffective for calcified gallstones.

Q: How soon do blood test results show if the medicine is working?

Bile acid concentrations in the body reach a stable level about three weeks after starting treatment. Liver function values are typically monitored on a monthly basis initially to check for response to the medicine.

Q: Is it safe to take Tylenol (acetaminophen) or ibuprofen (NSAIDs) with it?

No interactions have been specifically reported in official documentation for acetaminophen. However, the use of a related medicine in the NSAID class, acetylsalicylic acid, may increase the risk of specific adverse effects.

Q: Why does it not work for some patients?

Official documentation acknowledges that complete gallstone dissolution does not occur in all patients. Treatment for gallstones that are calcified (radio-opaque) is ineffective. Individual response is a known variable in the treatment of chronic liver disease.

Q: Is it effective in preventing the progression of liver disease (based on studies)?

Research focused on the approved use in primary biliary cholangitis has examined the medicine’s ability to affect disease progression. Studies have reported measured patterns related to reducing the incidence of, and delaying the time to, certain major disease milestones.

Q: Does it affect my body weight or metabolism?

The drug is officially approved for preventing gallstone formation in patients undergoing rapid weight loss. Also, some patients in clinical studies have reported a possible side effect of unusual weight gain or loss.

Q: Is it safe for older adults or elderly patients?

Official summaries indicate that no significant differences in safety or effectiveness have been identified between older adults and younger adults. Regulatory information indicates that selection of dosing is advised to be done with caution for elderly patients.

Q: What are the signs of a serious allergic reaction?

Signs of a serious allergic reaction, as listed in patient information, include swelling of the face, eyes, lips, tongue, or throat. Other signs are difficulty breathing or swallowing, hives, and rash.

Q: Is it safe to use with other bile acid medications?

Official product information states that the medicine should not be taken concomitantly with bile acid sequestrants (such as cholestyramine) or antacids containing aluminum. These substances can bind the active ingredient and inhibit its absorption, reducing its effectiveness.

Q: Does it cause diarrhea, and if so, why?

Diarrhea and pasty stools are described as common side effects reported in clinical trials. In cases where severe diarrhea occurs, official information notes that a reduction in the prescribed dose is a common clinical measure.

Q: Can I take the oral suspension form?

Yes, official regulatory documents describe the oral suspension as a form that can be used when a patient cannot swallow the solid dosage forms, such as capsules or tablets.

Q: Is it safe to use during pregnancy or while breastfeeding?

Official regulatory warnings state that use during pregnancy is not recommended unless deemed clearly necessary. While low levels of the active substance may pass into human milk, adverse effects in the breastfed infant are not expected.

Q: Can I stop taking it suddenly?

Official patient information notes that therapy should not be discontinued without consulting a healthcare provider. This is because treatment for indications like gallstone dissolution often requires many months for the intended effect to be achieved.

Q: Is it available as an oral capsule, tablet, or suspension?

Yes, according to official regulatory labels, the medication is available in various solid forms, including oral capsules and tablets, as well as an oral suspension form.

How should Ursodil be stored and disposed of?

Storage and Disposal of Ursodiol

Ursodiol (ursodeoxycholic acid) must be stored in accordance with official regulatory requirements to maintain its stability and effectiveness.


Official Storage Conditions

Storage Category Requirement
Temperature Store at controlled room temperature (20 C to 25 C / 68 F to 77 F), keeping it from freezing or excess heat.
Protection Keep away from direct light and moisture (e.g., not in the bathroom).
Container The medication must remain in its original container, which should be tightly closed.

Handling and Stability

  • Keep this medication strictly out of the reach of children.
  • Scored tablets, once broken, have an in-use stability limit; the half-tablets must be used within 28 days and should be stored separately.
  • Do not keep outdated medicine.

Disposal Instructions

Disposal must follow local regulations. Unused or expired Ursodiol should be discarded using a drug take-back program. If no program is available, the product may be mixed with an undesirable substance (e.g., coffee grounds) in a sealed bag and placed in the household trash, with all personal information removed from the label. It should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ursodil found in:

A-Z Index: